Energy balance pathway

The term "energy balance pathway" refers collectively to the complex web of biochemical reactions and regulatory mechanisms that maintain equilibrium between energy intake (from nutrients), storage (as glycogen/fat), and expenditure (via basal metabolism, physical activity, thermogenesis)[2][4]. These include major metabolic routes such as glycolysis, citric acid cycle/Krebs cycle/TCA cycle, oxidative phosphorylation/respiratory chain activity in mitochondria—as well as hormonal signaling networks involving insulin, glucagon, leptin, ghrelin and others that sense nutrient status and adjust cellular responses accordingly[2][3]. These processes are essential for survival at both cellular and organismal levels. Disruptions can lead to diseases including obesity and diabetes. The regulation involves both anabolic pathways (which require input of energy to build complex molecules from simpler ones) and catabolic pathways (which break down complex molecules into simpler ones while releasing stored chemical energy)[3][6]. As described by sources: “A biological pathway is a series of actions among molecules in a cell that leads to a certain product or change... Metabolic pathways make possible the chemical reactions that occur in our bodies. An example...is the process by which cells break down food into energy molecules...”[1] In summary, "Energy balance pathway" should be considered shorthand for multiple interrelated molecular targets/processes—not itself suitable as an individual drug target entry. This term does not refer to a discrete therapeutic target such as an enzyme, receptor, transporter, or other druggable biomolecule. It is not classified as enzyme/receptor/transporter/etc., but as an integrated network/process involving many molecules[1][2]. No drugs directly interact with "energy balance pathway" itself; drugs may modulate components within these networks such as enzymes or receptors involved in metabolism. There is no universal biomarker for the entire "energy balance pathway"; biomarkers exist for specific nodes/components such as blood glucose for carbohydrate metabolism. Similarly, no general safety profile exists for targeting an entire physiological process; safety concerns depend on which part/component is targeted. If you need structured information about specific components within this system—such as AMP‑activated protein kinase (AMPK), insulin receptor (INSR), glucagon-like peptide‑1 receptor (GLP‑1R)—please specify those targets individually.

Other names

Energy metabolism pathwaysMetabolic pathways regulating energy homeostasisBioenergetic pathways

Mechanisms are diverse depending on which component(s) within the broader network are targeted—e.g., inhibition/activation of enzymes like AMPK, modulation of hormone receptors like insulin receptor.